{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:55:23Z","timestamp":1774608923831,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.beem.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T22:17:41Z","timestamp":1466288261000},"page":"345-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?"],"prefix":"10.1016","volume":"30","author":[{"given":"Alice P.S.","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea O.Y.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.beem.2016.06.003_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N\u00a0Engl J\u00a0Med"},{"issue":"20","key":"10.1016\/j.beem.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"issue":"9712","key":"10.1016\/j.beem.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0140-6736(09)60937-5","article-title":"Diabetes in Asia","volume":"375","author":"Ramachandran","year":"2009","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.beem.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0168-8227(98)00038-2","article-title":"Assessing the potential for alpha-glucosidase inhibitors in prediabetic states","volume":"40","author":"Holman","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"issue":"24","key":"10.1016\/j.beem.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with T2DM","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.beem.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in T2DM","volume":"358","author":"Gerstein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.beem.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrendo.2013.102","article-title":"Diabetes and its comorbidities-where East meets West","volume":"9","author":"Kong","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in T2DM, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2016.06.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc13-2507","article-title":"Severe hypoglycemia identifies vulnerable patients with T2DM at risk for premature death and all-site cancer: the Hong Kong Diabetes Registry","volume":"37","author":"Kong","year":"2014","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.beem.2016.06.003_bib10","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2011-0246","article-title":"Preservation of beta-cell function: the key to diabetes prevention","volume":"96","author":"DeFronzo","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/dmrr.1092","article-title":"The A1C and ABCD of glycaemia management in T2DM: a physician's personalized approach","volume":"26","author":"Pozzilli","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2016.06.003_bib13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N.\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of T2DM with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2337\/dc08-1980","article-title":"Sleep duration, lifestyle intervention, and incidence of T2DM in impaired glucose tolerance: the Finnish Diabetes Prevention Study","volume":"32","author":"Tuomilehto","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with T2DM (UKPDS 33)","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.beem.2016.06.003_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in T2DM","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.beem.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00125-009-1352-5","article-title":"Megatrials in T2DM. From excitement to frustration?","volume":"52","author":"Del Prato","year":"2009","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.beem.2016.06.003_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1742-1241.2009.02227.x","article-title":"Tailoring treatment to the individual in T2DM practical guidance from the global partnership for effective diabetes management","volume":"64","author":"Del Prato","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"35","key":"10.1016\/j.beem.2016.06.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17350","article-title":"Screening for T2DM: a short report for the national screening committee","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.beem.2016.06.003_bib21","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2011"},{"issue":"3","key":"10.1016\/j.beem.2016.06.003_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diabres.2008.09.006","article-title":"Use of anti-diabetic drugs and glycaemic control in T2DM-The Hong Kong Diabetes Registry","volume":"82","author":"Tong","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.beem.2016.06.003_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/oxfordjournals.aje.a116732","article-title":"Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States","volume":"137","author":"Cowie","year":"1993","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.beem.2016.06.003_bib24","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2002-021864","article-title":"Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis","volume":"88","author":"Ferrannini","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.06.003_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2016.06.003_bib26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease. Banting lecture 1988","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2016.06.003_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1573399810602040397","article-title":"The role of Adipocytokines and neurohormonal dysregulation in metabolic syndrome","volume":"2","author":"Kong","year":"2006","journal-title":"Curr Diabetes Rev"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-5448.2008.00410.x","article-title":"Associations of overweight with insulin resistance, beta-cell function and inflammatory markers in Chinese adolescents","volume":"9","author":"Kong","year":"2008","journal-title":"Pediatr Diabetes"},{"issue":"6 Pt 1","key":"10.1016\/j.beem.2016.06.003_bib29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.103.6.1175","article-title":"The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study","volume":"103","author":"Freedman","year":"1999","journal-title":"Pediatrics"},{"issue":"23","key":"10.1016\/j.beem.2016.06.003_bib30","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.beem.2016.06.003_bib31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of hypogonadism in males aged at least 45 years: the HIM study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J\u00a0Clin Pract"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/dc06-1579","article-title":"Androgens and diabetes in men: results from the third national health and nutrition Examination survey (NHANES III)","volume":"30","author":"Selvin","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib33","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone-binding globulin, and the development of T2DM in middle-aged men: prospective results from the Massachusetts male aging study","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000329339","article-title":"Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study","volume":"73","author":"Tam","year":"2011","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib37","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1464-5491.2010.02993.x","article-title":"A\u00a0simple risk score to identify Southern Chinese at high risk for diabetes","volume":"27","author":"Ko","year":"2010","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.beem.2016.06.003_bib39","first-page":"22","article-title":"Reorganising diabetes care through knowledge transfer","volume":"18","author":"Chan","year":"2013","journal-title":"Hong Kong Med Diary"},{"issue":"3","key":"10.1016\/j.beem.2016.06.003_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.diabres.2012.09.005","article-title":"Risk scores based on self-reported or available clinical data to detect undiagnosed T2DM: a systematic review","volume":"98","author":"Brown","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2016.06.003_bib41","first-page":"S20","article-title":"Prevention\/Delay of diabetes","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib42","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc12-1235","article-title":"Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis","volume":"36","author":"Kodama","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2016.06.003_bib43","series-title":"Other disorders with type 1 phenotype. Textbook of diabetes","author":"Kong","year":"2010"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db12-0207","article-title":"Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in\u00a0China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study","volume":"62","author":"Zhou","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.beem.2016.06.003_bib46","doi-asserted-by":"crossref","first-page":"e28311","DOI":"10.1371\/journal.pone.0028311","article-title":"A\u00a0cross-sectional characterization of insulin resistance by phenotype and insulin clamp in East Asian Americans with type 1 and T2DM","volume":"6","author":"Hsu","year":"2011","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.beem.2016.06.003_bib47","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.beem.2016.06.003_bib48","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2016.06.003_bib49","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.ijo.0802398","article-title":"Sonographic measurement of mesenteric fat thickness and its association with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes","volume":"27","author":"Liu","year":"2003","journal-title":"Int J Obes"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib50","first-page":"787","article-title":"Mesenteric fat thickness as an independent determinant of nonalcoholic fatty liver","volume":"30","author":"Liu","year":"2006","journal-title":"Int J\u00a0Obes"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2004.10.038","article-title":"Association of carotid intima-media thickness with mesenteric, preperitoneal and subcutaneous fat thickness","volume":"179","author":"Liu","year":"2005","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.ijo.0803201","article-title":"Mesenteric fat thickness as an independent determinant of fatty liver","volume":"30","author":"Liu","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2016.06.003_bib54","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and\u00a0older men: estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib55","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of symptomatic androgen deficiency in men","volume":"92","author":"Araujo","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.06.003_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2337\/diab.43.2.212","article-title":"Insulin resistance, body fat distribution, and sex hormones in men","volume":"43","author":"Haffner","year":"1994","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.beem.2016.06.003_bib57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2010.03942.x","article-title":"Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy","volume":"74","author":"Hamilton","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib58","first-page":"534","article-title":"Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth","volume":"29","author":"Basaria","year":"2008","journal-title":"J\u00a0Androl"},{"issue":"27","key":"10.1016\/j.beem.2016.06.003_bib59","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib60","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1210\/en.2003-0741","article-title":"Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1\/2 pluripotent cells through an androgen receptor-mediated pathway","volume":"144","author":"Singh","year":"2003","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.beem.2016.06.003_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2605.2010.01061.x","article-title":"Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle","volume":"34","author":"Haren","year":"2011","journal-title":"Int J Androl"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib62","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.22252","article-title":"Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor","volume":"47","author":"Lin","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with T2DM: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib64","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in T2DM","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib65","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2007-2177","article-title":"Low testosterone levels are common and associated with insulin resistance in men with diabetes","volume":"93","author":"Grossmann","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib66","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of T2DM: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib67","first-page":"1140","article-title":"Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men","volume":"76","author":"Vermeulen","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2016.06.003_bib68","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1210\/en.2003-0644","article-title":"Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats","volume":"144","author":"Watanobe","year":"2003","journal-title":"Endocrinology"},{"issue":"5487","key":"10.1016\/j.beem.2016.06.003_bib69","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Bruning","year":"2000","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.beem.2016.06.003_bib70","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.beem.2016.06.003_bib71","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib72","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib73","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1464-5491.2010.03205.x","article-title":"Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008","volume":"28","author":"Zhang","year":"2010","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib74","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-12-0452","article-title":"Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes","volume":"167","author":"Morkrid","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2016.06.003_bib75","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.beem.2016.06.003_bib76","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2016.06.003_bib77","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)12131-1","article-title":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic critera. The DeCODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe","volume":"354","author":"The DECODE Study Group","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","article-title":"The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program","volume":"24","author":"Diabetes Prevention Program Research Group","year":"2007","journal-title":"Diabet Med"},{"issue":"7588","key":"10.1016\/j.beem.2016.06.003_bib79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay T2DM in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.beem.2016.06.003_bib80","doi-asserted-by":"crossref","first-page":"543","DOI":"10.7326\/0003-4819-159-8-201310150-00007","article-title":"Lifestyle interventions for patients with and at risk for T2DM: a\u00a0systematic review and meta-analysis","volume":"159","author":"Schellenberg","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.beem.2016.06.003_bib81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabres.2015.01.027","article-title":"Preventing the progression to T2DM in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions","volume":"107","author":"Stevens","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.beem.2016.06.003_bib82","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Role of insulin secretion and sensitivity in the evolution of T2DM in the diabetes prevention program: effects of lifestyle intervention and metformin","volume":"54","author":"Kitabchi","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2016.06.003_bib83","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of T2DM with troglitazone in the diabetes prevention program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.beem.2016.06.003_bib84","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N\u00a0Engl J\u00a0Med"},{"issue":"9323","key":"10.1016\/j.beem.2016.06.003_bib85","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of T2DM mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"issue":"9675","key":"10.1016\/j.beem.2016.06.003_bib86","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of T2DM mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance","volume":"373","author":"Kawamori","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib87","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by\u00a0obesity: plasma metabolomic approach using GC-MS","volume":"58","author":"Escobar-Morreale","year":"2011","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.beem.2016.06.003_bib88","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.beem.2016.06.003_bib89","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jdi.12288","article-title":"Testosterone level in men with T2DM and related metabolic effects: a review of current evidence","volume":"6","author":"Cheung","year":"2014","journal-title":"J\u00a0Diabetes Investig"},{"issue":"18","key":"10.1016\/j.beem.2016.06.003_bib90","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1503\/cmaj.150033","article-title":"Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline","volume":"187","author":"Morales","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.beem.2016.06.003_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2016.04.007","article-title":"Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions","author":"Morgentaler","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2016.06.003_bib92","first-page":"1","article-title":"Effects of testosterone replacement therapy on cardio-metabolic, hormonal and anthropometric parameters in obese hypogonadal men with metabolic syndrome","volume":"1.2","author":"Nedogoda","year":"2015","journal-title":"Obesity: Open Access"},{"issue":"6","key":"10.1016\/j.beem.2016.06.003_bib93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc13-0512","article-title":"Personalized management of hyperglycemia in T2DM: reflections from a Diabetes Care editors' expert forum","volume":"36","author":"Raz","year":"2013","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2016.06.003_bib94","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2337\/dc15-S010","article-title":"Standards of medical care in diabetes","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X16300203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X16300203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:50:03Z","timestamp":1761497403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X16300203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1521690X16300203"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2016.06.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}